It would not be the first therapy that may promote spread while curing the primary site. Hopefully there are measures to assess the cost / benefits.

For sure. Goes without saying in any cancer treatment that cost/benefit is a prime consideration. Still, that will not stop me from asking the question. You can't do that analysis without the answers after all.